The utility of non-ophthalmologist examination of eyes at risk for serious retinopathy of prematurity

Ophthalmic Epidemiology

Volumn 18, Issue 6, 2011, Pages 264-268

  Zepeda Romero, Luz Consuelo ^a   Barrera De Len, Juan Carlos ^b   Gonzlez Bernal, Cesareo ^b   Marquez Amezcua, Mario ^c   Diaz Arteaga, Vernica ^d   Angulo Castellanos, Eusebio ^a   Gutiérrez Padilla, Jose Alfonso ^a   Gallardo Rincn, Hector ^e  

^a HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^b Children's Hospital   (Mexico)

^c Secretaria de Salud Jalisco   (Mexico)

^d Health Department of the State of Jalisco   (Mexico)

^e Instituto Carlos Slim de la Salud AC   (Mexico)

Author keywords

Blindness prevention; Non ophthalmologist; Plus disease; Retinopathy of prematurity detection

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EYE EXAMINATION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPE; OPHTHALMOSCOPY; PEDIATRICIAN; PHYSICIAN; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

CHI-SQUARE DISTRIBUTION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MEXICO; NEONATAL SCREENING; NEONATOLOGY; OPHTHALMOSCOPY; PEDIATRICS; RETINOPATHY OF PREMATURITY; STATISTICS, NONPARAMETRIC;

EID: 80755125555     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2011.602506     Document Type: Article

References (13)

1. Saunders RA, Donahue ML, Berland JE, Roberts EL, Von Powers B, Rust PF. Non-ophthalmologist screening for retin-opathy of prematurity. Br J Ophthalmol 2000;84:130-134.
2. Saunders RA, Bluestein EC, Berland JE, Donahue ML, Wilson ME, Rust PF. Can non-ophthalmologists screen for retin-opathy of prematurity? J Pediatr Ophthalmol Strabismus 1995;32:302-304
3. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005;115:e518-525. (Pubitemid 43843209)
4. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet 1997:5;350:12-14.
5. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008;84:77-82.
6. Azad RV, Manjunatha NP, Pal N, Deorari AK. Retinopathy of prematurity screening by non-retinologists. Indian J Pediatr 2006;73:515-318.
7. Saunders RA, Bluestein EC, Sinatra RB, Wilson ME, O'Neil JW, Rust PF. The predictive value of posterior pole vessels in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 1995;32:82-85.
8. Skalet AH, Quinn GE, Ying GS, et al. Telemedicine screening for retinopathy of prematurity in developing countries using digital retinal images: a feasibility project. J AAPOS 2008;12:252-258.
9. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopa-thy of prematurity randomized trial. Arch Ophthalmol 2003; 121:1684-1694.
10. Wallace DK, Kylstra JA, Chesnutt DA. Prognostic signifcance of vascular dilation and tortuosity insuffcient for plus disease in retinopathy of prematurity. J AAPOS 2000;4:224-229.
11. International Committee for the Classifcation of Retinopathy of Prematurity. The International Classifcation of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991-999.
12. Phelps D. Its Plus disease, isn't it? Arch Ophthalmol 2007;125:963-964.
13. Good WV. Screening for retinopathy of prematurity: no ophthalmologist required? Br J Ophthalmol 2000;84:127-128. (Pubitemid 30251652)